Methotrexate-induced renal oxidative stress in rats: The role of a novel antioxidant caffeic acid phenethyl ester

Toxicology and Industrial Health

Volumn 22, Issue 6, 2006, Pages 241-247

  Öktem, Faruk ^a   Yilmaz, H Ramazan ^a   Ozguner, Fehmi ^a   Olgar, Seref ^a   Ayata, Ali ^a   Uzar, Ertugrul ^a   Uz, Efkan ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

caffeic acid phenethyl ester; kidney; methotrexate; oxidative stress

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHOTREXATE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; CAFFEIC ACIDS; CATALASE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; METHOTREXATE; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 33746878465     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1191/0748233706th265oa     Document Type: Article

References (39)

1. Abelson, H. T., Fosburg, M. T. and Beardsley, G. P. et al. 1983: Methotrexate induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucov-orin and thymidine. Journal of Clinical Oncology 1, 208-216.
2. Aebi, Y. 1984: Catalase in vitro. Methods in Enzymology 105, 121-126.
3. Babiak, R. M., Campello, A. P., Carnieri, E. G. and Oliveira, M. B. 1989: Methotrexate: pentose cycle and oxidative stress. Cell Biochemistry and Function 16, 283-293.
4. Balogun, E., Hoque, M. and Gong, P. et al. 2003: Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Society 371, 887-895.
5. Caetano, N. N., Campello, A. P. and Carnieri, E. G. S. et al. 1997: Effects of methotrexate (methotrexate) on NAD(P)- dehydrogenases of HeLa cells: malic enzymes, 2-oxoglutarate and isocitrate dehydrogenases. Cell Biochemistry and Function 15, 259-264.
6. Capel, I. D., Leach, D. and Dorrell, H. M. 1983: Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Research 3, 59-62.
7. Chen, Y. J., Shiao, M. S. and Wang, S. Y. 2001: The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 12, 143-149.
8. Deray, G., Khayat, D. and Cacoub, P. et al. 1989: The effects of diltiazem on methotrexate-induced nephrotoxicity. European Journal of Clinical Pharmacology 37, 337-340.
9. Draper, H. H. and Hadley, M. 1990: Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186, 421-431.
10. Fesen, M. R., Pommier, Y. and Leteurtre, E. et al. 1994: Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (Caffeic Ester) and related compounds. Biochemical Pharmacology 48, 595-608.
11. Fuskevag, O. M., Kristiansen, C. and Olsen, R. et al. 2000: Microvascular perturbations in rats receiving the maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate. Ultrastructural Pathology 24, 325-332.
12. Gurer, H. and Ercal, N. 2000: Can antioxidants be beneficial in the treatment of lead poisoning? Free Radical Biology and Medicine 29, 927-945.
13. Heenen, M., Laporte, M. and De Graef, C. 1988: Methotrexate induces apoptotic cell death in human keratinocytes. Archives for Dermatological Research 290, 240-245.
14. Hempel, L., Misselwitz, J. and Fleck, C. et al. 2003: Influence of high-dose methotrexate therapy (HD-methotrexate) on glomerular and tubular kidney function. Medical and Pediatric Oncology 40, 348-354.
15. Jahovic, N., Cevik, H. and Sehirli, A. O. et al. 2003: Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. Journal of Pineal Research 34, 282-287.
16. Jolivet, J., Cowan, K. H. and Curt, G. A. et al. 1983: The pharmacology and clinical use of methotrexate. New England Journal of Medicine 309, 1094-1104.
17. Kroger, H., Hauschild, A. and Ohde, M. et al. 1999: Nicotinamide and methionine reduce the liver toxic effect of methotrexate. General Pharmacology 33, 203-206.
18. Lee, S. M., Koh, H. J. and Park, D. C. et al. 2002: Cytosolic NADP (-/)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radical Biology and Medicine 32, 1185-1196.
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. 1951: Protein measurement with the folin phenol reagent. Journal of Clinical Chemistry 193, 265-269.
20. Michaluart, P., Masferrer, J. L. and Carothers, A. M. et al. 1999: Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in rat model of inflammation. Cancer Research 59, 2347-2352.
21. Miyazono, Y., Gao, F. and Horie, T. 2004: Oxidative stress contributes to methotrexate-induced small intestinal toxi-city in rats. Scandinavian Journal of Gastroenterology 39, 1119-1127.
22. Oktem, F., Arslan, M. K. and Dündar, B. et al. 2004: Renal effects and erythrocyte oxidative stress in long term lead-exposed adolescent workers in auto repair workshops. Archives of Toxicology 78, 681-687.
23. Oktem, F., Ozguner, F. and Sulak, O. et al. 2005: Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Molecular and Cellular Biochemistry 277, 109-115.
24. Ozen, S., Akyol, O. and Iraz, M. et al. 2004: Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology 24, 27-35.
25. Ozguner, F., Oktem, F. and Armagan, A. et al. 2005a: Comparative analysis of the protective effects of melatonin and caffeic acid phenethyl ester (CAPE) on 900 MHz emitted mobile phone-induced renal impairment in rat. Molecular and Cellular Biochemistry 276, 31-37.
26. Ozguner, F., Armagan, A. and Koyu, A. et al. 2005b: A novel antioxidant agent caffeic acid phenethyl ester (CAPE) prevents shock wave-induced renal tubular oxidative stress. Urological Research 33, 239-243.
27. Ozyurt, H., Irmak, M. K., Akyol, O. and Sogut, S. 2001: Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemiareperfusion injury. Cell Biochemistry and Function 19, 259-263.
28. Paglia, D. E. and Valentine, W. N. 1967: Studies on the quantitative and qualitative characterization of erythrocyte GSH peroxidase. The Journal of Laboratory Clinical Medicine 70, 158-169.
29. Parlakpinar, H., Tasdemir, S. and Polat, A. et al. 2005: Protective role of caffeic acid phenethyl ester (CAPE) on gentamicin-induced acute renal toxicity in rats. Toxicology 207, 169-177.
30. Rao, C., Desai, D. and Kaul, B. et al. 1992: Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chemico-Biological Interactions 84, 277-290.
31. Schornagel, J. H. and McVie, J. G. 1983: The clinical pharmacology of methotrexate. Cancer Treatment Reviews 10, 53-57.
32. Smeland, E., Fuskevag, O. M. and Nymann, K. et al. 1996: High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model. Cancer Chemotherapy and Pharmacology 37, 415-422.
33. Subramaniam, S. and Shyamala Devi, C. S. 1995: Vitamin E protects intestinal basolateral membrane from CMF-induced damages in rat. Indian Journal of Physiology and Pharmacology 39, 263-266.
34. Sud'ina, G. F., Mirzoeva, O. K. and Pushkareva, G. A. et al. 1993: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters 329, 21-24.
35. Sun, Y., Oberley, L. W. and Li, Y. 1988: A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34, 497-500.
36. van Ede, A. E., Laan, R. F. J. M. and De Abreu, R. A. et al. 2002: Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Annals of the Rheumatic Diseases 61, 1060-1064.
37. Widemann, B. C., Balis, F. M. and Kempf-Bielack, B. et al. 2004: High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome. Cancer 100, 2222-2232.
38. Yamamoto, N. S., Lopes, L. C. V., Campello, A. P. and Kluppel, M. L. W. 1989: Methotrexate: studies on cellular metabolism. II. Effects on mitochondrial metabolism and ion transport. Cell Biochemistry and Function 7, 129-134.
39. Yilmaz, H. R., Uz, E. and Yucel, N. et al. 2004: Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. Journal of Biochemical and Molecular Toxicology 18, 234-238.